hydralazine has been researched along with Cirrhosis, Liver in 6 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypertension is an important risk factor for nonalcoholic steatohepatitis." | 5.56 | The antihypertensive agent hydralazine reduced extracellular matrix synthesis and liver fibrosis in nonalcoholic steatohepatitis exacerbated by hypertension. ( Asano, T; Hashimoto, S; Kitamori, K; Naito, H; Nakajima, T; Yuan, Y, 2020) |
| "Three patients developed hepatic injury two months, ten months and two years, respectively, after hydralazine therapy for hypertension." | 3.66 | Hydralazine-induced hepatitis. ( Ichinoe, A; Itoh, S; Itoh, Y; Tsukada, Y, 1981) |
| "Hypertension is an important risk factor for nonalcoholic steatohepatitis." | 1.56 | The antihypertensive agent hydralazine reduced extracellular matrix synthesis and liver fibrosis in nonalcoholic steatohepatitis exacerbated by hypertension. ( Asano, T; Hashimoto, S; Kitamori, K; Naito, H; Nakajima, T; Yuan, Y, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Sultan, LR | 1 |
| Karmacharya, MB | 1 |
| Al-Hasani, M | 1 |
| Cary, TW | 1 |
| Sehgal, CM | 1 |
| Yuan, Y | 1 |
| Naito, H | 1 |
| Kitamori, K | 1 |
| Hashimoto, S | 1 |
| Asano, T | 1 |
| Nakajima, T | 1 |
| Takeuchi, K | 1 |
| Yokouchi, C | 1 |
| Goto, H | 1 |
| Umehara, K | 1 |
| Yamada, H | 1 |
| Ishii, Y | 1 |
| SANCHETTI, P | 1 |
| FAVERO, S | 1 |
| Itoh, S | 1 |
| Ichinoe, A | 1 |
| Tsukada, Y | 1 |
| Itoh, Y | 1 |
| Isdale, JM | 1 |
| Thomson, PD | 1 |
| Katz, S | 1 |
6 other studies available for hydralazine and Cirrhosis, Liver
| Article | Year |
|---|---|
Hydralazine-augmented contrast ultrasound imaging improves the detection of hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Contrast Media; Humans; Hydralazine; Liver Cirrhosis; Liver Neop | 2023 |
The antihypertensive agent hydralazine reduced extracellular matrix synthesis and liver fibrosis in nonalcoholic steatohepatitis exacerbated by hypertension.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antihypertensive Agents; Blood Pre | 2020 |
Alleviation of fatty liver in a rat model by enhancing N
Topics: Aldehyde Oxidase; Animals; Biological Availability; Cytosol; Disease Models, Animal; Enzyme Inhibito | 2018 |
[CLINICAL STUDY OF A NEW COMPLEX HYPOTENSIVE DRUG COMBINATION].
Topics: Antihypertensive Agents; Arteriosclerosis; Carbamates; Cerebrovascular Disorders; Coronary Disease; | 1963 |
Hydralazine-induced hepatitis.
Topics: Chemical and Drug Induced Liver Injury; Female; Humans; Hydralazine; Hypertension; Liver; Liver Cirr | 1981 |
Infantile polycystic disease of the kidneys.
Topics: Child, Preschool; Chlorothiazide; Female; Guanethidine; Humans; Hydralazine; Hypertension, Renal; In | 1973 |